Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Obseva Sa Ordinary Shares (OBSV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting

- Abstract featuring-IMPLANT2 data awarded Prize Paper by Society for Assisted Reproductive Technology (SART)

OBSV : 17.27 (+1.29%)
ObsEva SA Announces Phase 3 IMPLANT 2 Clinical Trial Results of Nolasiban in IVF to be Presented at Annual ASRM Meeting Tuesday October 9, 2018

EQNX::TICKER_START (:OBSV), EQNX::TICKER_END

OBSV : 17.27 (+1.29%)
ObsEva SA reports additional positive Phase 3 results of IMPLANT 2 trial showing significant increase of Live Birth Rate (LBR) following IVF with Single Embryo Transfer (SET)

- Phase 3 IMPLANT 2 trial results showed Live Birth Rate increased by up to 35% with Nolasiban treatment

OBSV : 17.27 (+1.29%)
ObsEva (OBSV) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in ObsEva SA (OBSV).

OBSV : 17.27 (+1.29%)
Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for the treatment of endometriosis-associated pain

- Linzagolix overall efficacy and safety maintained or improved at week 24

OBSV : 17.27 (+1.29%)
Can the Rally in ObsEva (OBSV) Shares Continue?

ObsEva SA (OBSV) has been on the move lately as the stock has risen by 22.7% in the past four weeks, and it is currently trading well above its 20-Day SMA.

OBSV : 17.27 (+1.29%)
ObsEva SA to Participate in September Investor Conferences

Geneva, Switzerland and Boston, MA - August 28, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics...

OBSV : 17.27 (+1.29%)
New Research: Key Drivers of Growth for ObsEva SA, Gran Tierra Energy, Constellium N.V, Just Energy Group, Hovnanian Enterprises, and First Majestic Silver -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ObsEva SA (NASDAQ:OBSV), Gran...

OBSV : 17.27 (+1.29%)
CSTM : 10.32 (+1.57%)
AG : 6.27 (-0.48%)
GTE : 3.61 (+4.64%)
JE : 3.11 (+0.97%)
HOV : 1.57 (+3.29%)
ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018

ObsEva SA / ObsEva SA to Participate in Wedbush PacGrow Healthcare Conference August 14-15, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content...

OBSV : 17.27 (+1.29%)
ObsEva SA (OBSV) Reports Q2 Loss, Misses Revenue Estimates

ObsEva SA (OBSV) delivered earnings and revenue surprises of 9.26% and -100.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

OBSV : 17.27 (+1.29%)
ObsEva SA to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 8, 2018 / ObsEva SA (NASDAQ: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 8:00 AM Eastern Time.

OBSV : 17.27 (+1.29%)
ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update

ObsEva SA / ObsEva Reports Second Quarter 2018 Financial Results and Provides Business Update . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content...

OBSV : 17.27 (+1.29%)
ObsEva SA (OBSV) Sees Hammer Chart Pattern: Time to Buy?

ObsEva has been struggling lately, but the selling pressure may be coming to an end soon.

OBSV : 17.27 (+1.29%)
ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018

ObsEva SA / ObsEva SA to Hold Second Quarter 2018 Financial Results and Business Update Call on August 8, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 17.27 (+1.29%)
ObsEva Expands Executive Team Hiring a Chief Commercial Officer

ObsEva SA / ObsEva Expands Executive Team Hiring a Chief Commercial Officer . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement....

OBSV : 17.27 (+1.29%)
ObsEva SA Shares to Begin Trading on SIX Swiss Exchange

ObsEva SA / ObsEva SA Shares to Begin Trading on SIX Swiss Exchange . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

OBSV : 17.27 (+1.29%)
ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018

ObsEva SA / ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 17.27 (+1.29%)
ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)

ObsEva SA / ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109) . Processed...

OBSV : 17.27 (+1.29%)
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City

ObsEva SA / ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely...

OBSV : 17.27 (+1.29%)
Analysis: Positioning to Benefit within Fortress Transportation and Infrastructure Investors, Turquoise Hill Resources, FactSet Research, Shaw Communications, El Pollo Loco, and ObsEva SA -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fortress Transportation and...

TRQ : 1.93 (-1.03%)
OBSV : 17.27 (+1.29%)
FDS : 216.91 (+2.53%)
FTAI : 17.88 (+0.85%)
SJR : 19.15 (+1.92%)
LOCO : 13.03 (+2.92%)

Van Meerten Stock Picks

Tesla According to Peter Lynch
Today's Barchart Chart of the Day will be the auto maker Tesla (TSLA).
TSLA +17.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

cmdty Insider - Ag Market Commentary

Today's Commentary

Corn futures saw 3 cent losses in most nearby contracts Turnaround Tuesday profit taking. A drier pattern this week should allow producers in the Corn Belt to make better harvest progress. Monday’s Crop Progress indicated most WCB states laggin...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar